Fingerprint
Dive into the research topics of 'Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologics'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologics
Toshihiro Inokuchi, Sakuma Takahashi, Sakiko Hiraoka, Tatsuya Toyokawa, Shinjiro Takagi, Koji Takemoto, Jiro Miyaike, Tsuyoshi Fujimoto, Reiji Higashi, Yuki Morito, Toru Nawa, Seiyuu Suzuki, Mamoru Nishimura, Masafumi Inoue, Jun Kato, Hiroyuki Okada
Research output: Contribution to journal › Article › peer-review
9
Citations
(Scopus)